Birmingham, ALABAMA3 Active Studies

Chronic Lymphocytic Leukemia Clinical Trials in Birmingham, ALABAMA

Find 3 actively recruiting chronic lymphocytic leukemia clinical trials in Birmingham, ALABAMA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
991
Enrolling

Recruiting Chronic Lymphocytic Leukemia Studies in Birmingham

About Chronic Lymphocytic Leukemia Clinical Trials in Birmingham

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow that affects B lymphocytes. It is the most common type of adult leukemia. Treatment options include targeted therapies, chemotherapy, and immunotherapy.

There are currently 3 chronic lymphocytic leukemia clinical trials recruiting participants in Birmingham, ALABAMA. These studies are seeking a combined 991 participants. Research is being sponsored by Genmab, Juno Therapeutics, a Subsidiary of Celgene, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Lymphocytic Leukemia Clinical Trials in Birmingham — FAQ

Are there chronic lymphocytic leukemia clinical trials in Birmingham?

Yes, there are 3 chronic lymphocytic leukemia clinical trials currently recruiting in Birmingham, ALABAMA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What chronic lymphocytic leukemia treatments are being tested?

The 3 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for chronic lymphocytic leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov